<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02879604</url>
  </required_header>
  <id_info>
    <org_study_id>UF 9679</org_study_id>
    <nct_id>NCT02879604</nct_id>
  </id_info>
  <brief_title>Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia</brief_title>
  <acronym>Grecco</acronym>
  <official_title>Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Louis Mourier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Charles Perrens, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Strasbourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Center Alpes-Isère</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpitaux à Bron</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondation FondaMental</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Significant cognitive impairment (executive functions, memory, attention) is common in
      schizophrenia affecting up to 80% of patients. But pharmacological treatments (typical and
      atypical antipsychotic) do not have impact on cognitive functioning. For over 20 years,
      alternative non-pharmacological therapeutics have been developed in schizophrenia. These
      techniques called cognitive remediation specifically target cognitive deficits. The first
      cognitive remediation available for patients was designed to stimulate new learning, or
      relearning, of cognitive tasks, and thus to improve certain deficient domains. These
      procedures were efficient in improving cognition as measured by neurocognitive tests but
      their impact on functioning and daily life was weak. In a second time, compensatory
      remediation has been developed. Compensatory approaches seek to make improvements in the
      patient's functioning by avoiding areas of impairment and recruiting other intact cognitive
      domains or by creating a supportive external environment. In recent meta-analysis
      compensatory remediation has larger effect-size than classical cognitive remediation, with an
      impact on patients psychosocial functioning. Recently, Dr E. Twamley (University of
      California) developed and tested a group-based, manualized, compensatory cognitive training
      intervention.

      Compensatory cognitive training (CCT) is a low-tech, brief intervention and is easily
      transposable in community care. Our team translated this method into French. The
      investigators planned a cost -utility study between CCT and treatment as usual in
      schizophrenia patients with less than 10 years of evolution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will take place over 3 years with a recruitment period of 18 months. After
      verification of the eligibility criteria and signature of the consent, the patients will be
      divided into 2 groups by randomization: the intervention group and the control group. The
      duration of participation of the subjects will be 12 months. Assessments are available in 4
      steps (V1 at inclusion, V2 at 3 months, V3 at 6 months and V4 at 12 months). These visits
      include an assessment of the functioning of patients, symptomatology, quality of life,
      treatment and care received at all visits, occupational activity and cognitive assessment and
      social knowledge at V1 and V4.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2018</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cost-utility questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>Cost difference between the 2 group of patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functioning questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>FROGS, Functional Remission of General Schizophrenia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Compensatory cognitive training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Compensatory cognitive training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>usual treatment for shizophrenai</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Compensatory cognitive training</intervention_name>
    <description>In addition to the usual care, method of compensatory cognitive remediation</description>
    <arm_group_label>Compensatory cognitive training</arm_group_label>
    <other_name>CCT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual</intervention_name>
    <description>Usual care</description>
    <arm_group_label>usual treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnostic with schizophrénie

          -  Less than 10 years of the evolution of the disease

        Exclusion Criteria:

          -  History of severe cranial trauma and / or neurological pathology with cognitive
             impairment

          -  Ongoing participation in another study for treatment of negative or cognitive symptoms

          -  Ongoing participation in a study on management in psychotherapy for cognitive
             disorders and negative symptoms
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Delphine DC CAPDEVIELLE, MD-PhD</last_name>
    <role>Study Director</role>
    <affiliation>Montpellier University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Delphine CD Capdevielle, MD-PhD</last_name>
    <phone>+334 67 33 97 27</phone>
    <email>d-capdevielle@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane SR Raffard, PhD</last_name>
    <phone>+334 67 33 97 02</phone>
    <email>s-raffard@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charles Perrens Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David DM MISDRAHI, MD</last_name>
      <email>david.misdrahi@u-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Le Vinatier Hospital</name>
      <address>
        <city>Bron</city>
        <zip>69678</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain RR REY, MD</last_name>
      <email>Romain.REY@ch-le-vinatier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gabriel-Montpied Univesity Hospital</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Michel PL LLORCA, MD-PhD</last_name>
      <phone>+334 73 75 21 25</phone>
      <email>pmllorca@chu-clermontferrand.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle IC CHEREAU-BOUDET, MD</last_name>
      <phone>+334 73 75 21 25</phone>
      <email>ichereau@chu-clermontferrand.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Louis Mourier Hospital</name>
      <address>
        <city>Colombes</city>
        <zip>92701</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline CD DUBERTRET, MD-PhD</last_name>
      <phone>+331 47 60 64 16</phone>
      <email>caroline.dubertret@lmr.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Elisabeth EK KIESMANN, MD</last_name>
      <email>elisabeth.kiesmann@aphp.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Chenevier Hospital</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck FS SCHURHOFF, MD-PhD</last_name>
      <email>franck.schurhoff@inserm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>La Conception Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe CL LANCON, MD-PhD</last_name>
      <phone>+334 91 43 55 51</phone>
    </contact>
    <contact_backup>
      <last_name>Catherine CF FAGET, MD</last_name>
      <email>Catherine.faget@ap-hm.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Montpellier University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine DC CAPDEVIELLE, MD-PhD</last_name>
      <phone>+334 67 33 95 97</phone>
      <email>d-capdevielle@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Amandine AD DECOMBE</last_name>
      <phone>+334 67 33 54 35</phone>
      <email>a-decombe@chu-montpellier.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Alpes Isère Hospital</name>
      <address>
        <city>Saint-Égrève</city>
        <zip>38521</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien JD DUBREUCQ, MD</last_name>
      <email>jdubreucq@ch-alpes-isere.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Strasbourg University Hospital</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice FB BERNA, MD</last_name>
      <phone>+333 88 11 64 62</phone>
      <email>fabrice.berna@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Julie JC CLAUSS, MD</last_name>
      <email>JulieMarieEstelle.CLAUSS@chru-strasbourg.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 17, 2016</study_first_submitted>
  <study_first_submitted_qc>August 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2016</study_first_posted>
  <last_update_submitted>July 16, 2019</last_update_submitted>
  <last_update_submitted_qc>July 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cognitive remediation, cost-effectiveness analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

